Search hospitals > California > Bakersfield
Kern Research, Inc.
Claim this profileBakersfield, California 93301
Conducts research for Asthma
Conducts research for Chronic Urticaria
Conducts research for Atopic Dermatitis
Conducts research for Chronic Kidney Disease
Conducts research for Chronic Renal Failure
31 reported clinical trials
2 medical researchers
Summary
Kern Research, Inc. is a medical facility located in Bakersfield, California. This center is recognized for care of Asthma, Chronic Urticaria, Atopic Dermatitis, Chronic Kidney Disease, Chronic Renal Failure and other specialties. Kern Research, Inc. is involved with conducting 31 clinical trials across 43 conditions. There are 2 research doctors associated with this hospital, such as Eric Boren and Rajeev Krishan, MD.Top PIs
Eric BorenKern Research2 years of reported clinical research
Studies Chronic Urticaria
Studies Asthma
4 reported clinical trials
6 drugs studied
Rajeev Krishan, MDNational Institute of Clinical Research2 years of reported clinical research
Studies Ulcerative Colitis
Studies Psychogenic Colitis
2 reported clinical trials
1 drug studied
Clinical Trials running at Kern Research, Inc.
Asthma
Chronic Urticaria
Chronic Obstructive Pulmonary Disease
Injection Site Itch
Itching
Nasal polyps
Wheezing
Lower Respiratory Illness
Emphysema
Chronic Bronchitis
Dupilumab
for Asthma
This trial is testing dupilumab, a medication that reduces lung inflammation, in adults with moderate to severe asthma that isn't controlled by usual treatments. It aims to see if dupilumab can help improve breathing and slow down lung damage.
Recruiting2 awards Phase 48 criteria
Dupilumab + ICS/LABA
for Asthma
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condition where the airways narrow and swell, making it difficult to breathe. Uncontrolled asthma means that patients are still having frequent symptoms while taking their current asthma medication. The aim of the study is to see which regimen is more effective: taking dupilumab with an inhaled asthma medication or only taking a higher dose of the inhaled asthma medication. The type of asthma medication that will be used is a combination inhaled corticosteroid and long-acting beta-agonist (referred to as an ICS/LABA). Some patients may also receive an additional asthma medication called a long-acting muscarinic antagonist (referred to as a LAMA) if they are already receiving a LAMA. The study is also looking at: • What side effects may happen from taking dupilumab
Recruiting2 awards Phase 45 criteria
OM-85
for Recurrent Wheezing
This trial will test if daily OM-85 can reduce wheezing episodes in young children who often experience them. The study will focus on children aged 6 months to 5 years. OM-85 aims to help the immune system fight off infections that cause wheezing. OM-85 has been shown to reduce the risk of recurrent respiratory tract infections and wheezing attacks in children.
Recruiting0 awards Phase 25 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Kern Research, Inc.?
Kern Research, Inc. is a medical facility located in Bakersfield, California. This center is recognized for care of Asthma, Chronic Urticaria, Atopic Dermatitis, Chronic Kidney Disease, Chronic Renal Failure and other specialties. Kern Research, Inc. is involved with conducting 31 clinical trials across 43 conditions. There are 2 research doctors associated with this hospital, such as Eric Boren and Rajeev Krishan, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.